The prognostic value of modified Glasgow prognostic score in patients with esophageal squamous cell cancer: a Meta-analysis

References

• Domper Arnal MJ, Ferrandez Arenas A, Lanas Arbeloa A. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21(26):7933–7943.
   PubMed Web of Science ®Google Scholar
• Short MW, Burgers KG, Fry VT. Esophageal cancer. Am Fam Physician. 2017; 95(1):22–28.
   PubMed Web of Science ®Google Scholar
• Bollschweiler E, Plum P, Mönig SP, Hölscher AH. Current and future treatment options for esophageal cancer in the elderly. Expert Opin Pharmacother. 2017;18(10):1001–1010.
   PubMed Web of Science ®Google Scholar
• He W, Wei M, Yang X, Chen B, Wu Q, Zheng E, Deng X, Wang Z. Do inflammatory markers predict prognosis in patients with synchronous colorectal cancer?. Medicine (Baltimore). 2017;96(17):e6607.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Marchesi F, Porta C, Sica A, Allavena P. Inflammation and cancer: breast cancer as a prototype. Breast (Edinburgh, Scotland). 2007;16(Suppl 2):27–33.
   PubMed Web of Science ®Google Scholar
• Gao N, Yang R-N, Meng Z, Wang W-H. The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis. Biosci Rep. 2018;38(6):BSR20180686.
   PubMed Web of Science ®Google Scholar
• Yamauchi Y, Safi S, Muley T, Warth A, Herth FJF, Dienemann H, Hoffmann H, Eichhorn ME. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients. Lung cancer (Amsterdam, Netherlands). 2017;114:62–67.
   PubMed Web of Science ®Google Scholar
• Sun F, Ge X, Liu Z, Du S, Ai S, Guan W. Postoperative C-reactive protein/albumin ratio as a novel predictor for short-term complications following gastrectomy of gastric cancer. World J Surg Onc. 2017;15(1):191.
   PubMed Web of Science ®Google Scholar
• Wu M, Guo J, Guo L, Zuo Q. The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer. Tumor Biol. 2016;37(9):12525–12533.
   PubMedGoogle Scholar
• Liu Y, Chen S, Zheng C, Ding M, Zhang L, Wang L, Xie M, Zhou J. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer. BMC cancer. 2017; 17(1):285.
   PubMed Web of Science ®Google Scholar
• Otowa Y, Nakamura T, Yamamoto M, Kanaji S, Matsuda Y, Matsuda T, Oshikiri T, Sumi Y, Suzuki S, Kakeji Y, et al. C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II/III esophageal squamous cell cancer. Dis Esophagus Off J Int Soc Dis Esophagus. 2017; 30(12):1–5.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta analyses. Appl Eng Agric. 2012; 18:727–734.
   Google Scholar
• Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8(1):16.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed). 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455–463.
   PubMed Web of Science ®Google Scholar
• Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Iwahashi M, Nakamori M, Ojima T, Katsuda M, Iida T, Hayata K, Kato T, Yamaue H. New prognostic score for the survival of patients with esophageal squamous cell carcinoma. Surg Today. 2014; 44(5):875–883.
   PubMed Web of Science ®Google Scholar
• Arigami T, Okumura H, Matsumoto M, Uchikado Y, Uenosono Y, Kita Y, Owaki T, Mori S, Kurahara H, Kijima Y, et al. Analysis of the fibrinogen and neutrophil-lymphocyte ratio in esophageal squamous cell carcinoma: A promising blood marker of tumor progression and prognosis. Medicine (Baltimore). 2015;94(42):e1702.
   PubMed Web of Science ®Google Scholar
• Xu X-L, Yu H-Q, Hu W, Song Q, Mao W-M. A novel inflammation-based prognostic score, the c-reactive protein/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma. PLoS One. 2015;10(9):e0138657.
   PubMed Web of Science ®Google Scholar
• Otowa Y, Nakamura T, Takiguchi G, Tomono A, Yamamoto M, Kanaji S, Imanishi T, Suzuki S, Tanaka K, Itoh T, et al. Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer. Dis Esophagus. 2016;29(2):146–151.
   PubMed Web of Science ®Google Scholar
• Tian R, Zhang F, Sun P, Wu J, Yan H, Wu A-R, Zhang M, Jiang Y-L, Lu Y-H, Xu Q-Y, et al. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma. Oncotarget. 2016; 7(41):67485–67494.
   PubMedGoogle Scholar
• Chen P, Fang M, Wan QY, et al. High-sensitivity modified Glasgow prognostic score (HS-mGPS) Is superior to the mGPS in esophageal cancer patients treated with chemoradiotherapy. Oncotarget. 2017;8(59):99861–99870.
   PubMedGoogle Scholar
• Kunizaki M, Tominaga T, Wakata K, et al. Clinical significance of the C-reactive protein-to-albumin ratio for the prognosis of patients with esophageal squamous cell carcinoma. Mol Clin Onc. 2018;8(2):370–374.
   PubMed Web of Science ®Google Scholar
• Sun S, Chen P, Meng L, et al. High preoperative plasma fibrinogen and serum albumin score is associated with poor survival in operable esophageal squamous cell carcinoma. Dis Esophagus Off J Int Soc Dis Esophagus. 2018; 32(1).
   Google Scholar
• Zhang P, Xi M, Zhao L, et al. Comparison of two inflammation-based prognostic scores in patients with thoracic esophageal cancer undergoing chemoradiotherapy. Int J Clin Exp Med. 2016; 9(2):1764–1771.
   Web of Science ®Google Scholar
• Tan Z, Zhang M, Han Q, Wen J, Luo K, Lin P, Zhang L, Yang H, Fu J. A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the Fibrinogen/Albumin Ratio. J Cancer. 2017; 8(6):1025–1029.
   PubMed Web of Science ®Google Scholar
• Zhang L, Ma J, Han Y, et al. Targeted therapy in esophageal cancer. Expert Rev Gastroenterol Hepatol. 2016; 10(5):595–604.
   PubMed Web of Science ®Google Scholar
• Jackie Oh SJu, Han S, Lee W, Lockhart AC. Emerging immunotherapy for the treatment of esophageal cancer. Expert Opin Investig Drugs. 2016;Jun; 25(6):667–677.
   PubMed Web of Science ®Google Scholar
• Lasry A, Zinger A, Ben-Neriah Y. Inflammatory networks underlying colorectal cancer. Nat Immunol. 2016;17(3):230–240.
   PubMed Web of Science ®Google Scholar
• Lasry A, Ben-Neriah Y. Senescence-associated inflammatory responses: Aging and cancer perspectives. Trends Immunol. 2015;36(4):217–228.
   PubMed Web of Science ®Google Scholar
• Mariani F, Sena P, Roncucci L. Inflammatory pathways in the early steps of colorectal cancer development. World J Gastroenterol. 2014;20(29):9716–9731.
   PubMed Web of Science ®Google Scholar
• Nehring SM, Patel BC. C Reactive Protein (CRP). Treasure Island (FL): StatPearls Publishing LLC; 2018.
   Google Scholar
• Miyazaki T, Sakai M, Sohda M, Tanaka N, Yokobori T, Motegi Y, Nakajima M, Fukuchi M, Kato H, Kuwano1 H, et al. Prognostic significance of inflammatory and nutritional parameters in patients with esophageal cancer. Anticancer Res. 2016;36(12):6557–6562.
   PubMed Web of Science ®Google Scholar
• Arroyo V, Garcia-Martinez R, Salvatella X. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol. 2014;61(2):396–407.
   PubMed Web of Science ®Google Scholar
• Blank S, Nienhüser H, Dreikhausen L, Sisic L, Heger U, Ott K, Schmidt T. Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer. Oncotarget. 2017;8(29):47518–47532.
   PubMedGoogle Scholar
• Lv Y, Pan Y, Dong C, Liu P, Zhang C, Xing D. Modified Glasgow prognostic score at recurrence predicts poor survival in resected Non-Small Cell Lung Cancer (NSCLC) patients. Med Sci Monit. 2017;23:3780–3788.
   PubMed Web of Science ®Google Scholar
• Zhao X, Xu Z, Li H. NSAIDs use and reduced metastasis in cancer patients: Results from a meta-analysis. Sci Rep. 2017;7(1):1875.
   PubMed Web of Science ®Google Scholar